Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 169

1.

Punching above their weight: a network to understand broader determinants of increasing life expectancy.

Baum F, Popay J, Delany-Crowe T, Freeman T, Musolino C, Alvarez-Dardet C, Ariyaratne V, Baral K, Basinga P, Bassett M, Bishai DM, Chopra M, Friel S, Giugliani E, Hashimoto H, Macinko J, McKee M, Nguyen HT, Schaay N, Solar O, Thiagarajan S, Sanders D.

Int J Equity Health. 2018 Aug 13;17(1):117. doi: 10.1186/s12939-018-0832-y.

2.

NS3 Variability in Hepatitis C Virus Genotype 1A Isolates from Liver Tissue and Serum Samples of Treatment-Naïve Patients with Chronic Hepatitis C.

D'Aliberti D, Cacciola I, Musolino C, Raffa G, Filomia R, Alibrandi A, Benfatto S, Beninati C, Saitta C, Giosa D, Romeo O, Raimondo G, Pollicino T.

Intervirology. 2018;61(1):1-8. doi: 10.1159/000489307. Epub 2018 Jul 18.

PMID:
30021203
3.

The adipose organ and multiple myeloma: Impact of adipokines on tumor growth and potential sites for therapeutic intervention.

Allegra A, Innao V, Gerace D, Allegra AG, Vaddinelli D, Bianco O, Musolino C.

Eur J Intern Med. 2018 Jul;53:12-20. doi: 10.1016/j.ejim.2018.05.033. Epub 2018 May 30. Review.

PMID:
29859797
4.

Positioning relapse and recovery through a cultural lens of desire: A South Australian case study of disordered eating.

Musolino C, Warin M, Gilchrist P.

Transcult Psychiatry. 2018 Aug;55(4):534-550. doi: 10.1177/1363461518778669. Epub 2018 May 31.

PMID:
29848200
5.

Nanobodies and Cancer: Current Status and New Perspectives.

Allegra A, Innao V, Gerace D, Vaddinelli D, Allegra AG, Musolino C.

Cancer Invest. 2018 Apr 21;36(4):221-237. doi: 10.1080/07357907.2018.1458858. Epub 2018 Apr 16. Review.

PMID:
29658806
6.

Altered microRNA expression profile in the peripheral lymphoid compartment of multiple myeloma patients with bisphosphonate-induced osteonecrosis of the jaw.

Musolino C, Oteri G, Allegra A, Mania M, D'Ascola A, Avenoso A, Innao V, Allegra AG, Campo S.

Ann Hematol. 2018 Jul;97(7):1259-1269. doi: 10.1007/s00277-018-3296-7. Epub 2018 Mar 15.

PMID:
29546453
7.

Benefit-risk profile of cytoreductive drugs along with antiplatelet and antithrombotic therapy after transient ischemic attack or ischemic stroke in myeloproliferative neoplasms.

De Stefano V, Carobbio A, Di Lazzaro V, Guglielmelli P, Iurlo A, Finazzi MC, Rumi E, Cervantes F, Elli EM, Randi ML, Griesshammer M, Palandri F, Bonifacio M, Hernandez-Boluda JC, Cacciola R, Miroslava P, Carli G, Beggiato E, Ellis MH, Musolino C, Gaidano G, Rapezzi D, Tieghi A, Lunghi F, Loscocco GG, Cattaneo D, Cortelezzi A, Betti S, Rossi E, Finazzi G, Censori B, Cazzola M, Bellini M, Arellano-Rodrigo E, Bertozzi I, Sadjadian P, Vianelli N, Scaffidi L, Gomez M, Cacciola E, Vannucchi AM, Barbui T.

Blood Cancer J. 2018 Feb 28;8(3):25. doi: 10.1038/s41408-018-0048-9.

8.

Curcumin ameliorates the in vitro efficacy of carfilzomib in human multiple myeloma U266 cells targeting p53 and NF-κB pathways.

Allegra A, Speciale A, Molonia MS, Guglielmo L, Musolino C, Ferlazzo G, Costa G, Saija A, Cimino F.

Toxicol In Vitro. 2018 Mar;47:186-194. doi: 10.1016/j.tiv.2017.12.001. Epub 2017 Dec 6.

PMID:
29223572
9.

Inflammatory and Anti-Inflammatory Equilibrium, Proliferative and Antiproliferative Balance: The Role of Cytokines in Multiple Myeloma.

Musolino C, Allegra A, Innao V, Allegra AG, Pioggia G, Gangemi S.

Mediators Inflamm. 2017;2017:1852517. doi: 10.1155/2017/1852517. Epub 2017 Sep 26. Review.

10.

Flavocoxid exerts a potent antiviral effect against hepatitis B virus.

Pollicino T, Musolino C, Irrera N, Bitto A, Lombardo D, Timmoneri M, Minutoli L, Raimondo G, Squadrito G, Squadrito F, Altavilla D.

Inflamm Res. 2018 Jan;67(1):89-103. doi: 10.1007/s00011-017-1099-2. Epub 2017 Oct 10.

PMID:
29018874
11.

High BCR-ABL/GUSIS Levels at Diagnosis of Chronic Phase CML Are Associated with Unfavorable Responses to Standard-Dose Imatinib.

Vigneri P, Stagno F, Stella S, Cupri A, Forte S, Massimino M, Antolino A, Siragusa S, Mannina D, Impera SS, Musolino C, Malato A, Mineo G, Tomaselli C, Murgano P, Musso M, Morabito F, Molica S, Martino B, Manzella L, Müller MC, Hochhaus A, Raimondo FD.

Clin Cancer Res. 2017 Dec 1;23(23):7189-7198. doi: 10.1158/1078-0432.CCR-17-0962. Epub 2017 Sep 19.

PMID:
28928163
12.

Immunoproteasome-selective and non-selective inhibitors: A promising approach for the treatment of multiple myeloma.

Ettari R, Zappalà M, Grasso S, Musolino C, Innao V, Allegra A.

Pharmacol Ther. 2018 Feb;182:176-192. doi: 10.1016/j.pharmthera.2017.09.001. Epub 2017 Sep 11. Review.

PMID:
28911826
13.

Spontaneous Healing of Clodronate-Related Osteonecrosis of the Jaw.

Nastro Siniscalchi E, Allegra A, De Ponte FS, Oteri G, Cervino G, Lauritano F, Musolino C, Cicciù M.

J Craniofac Surg. 2017 Oct;28(7):e687-e689. doi: 10.1097/SCS.0000000000003837.

PMID:
28857991
14.

Ponatinib-Induced Graft-versus-Host Disease/Graft-versus-Leukemia Effect in a Patient with Philadelphia-Positive Acute Lymphoblastic Leukemia without the T315I Mutation Relapsing after Allogeneic Transplant.

Petrungaro A, Gentile M, Mazzone C, Greco R, Uccello G, Recchia AG, De Stefano L, Bossio S, Palummo A, Morelli R, Musolino C, Morabito F, Vigna E.

Chemotherapy. 2017;62(6):353-356. doi: 10.1159/000477714. Epub 2017 Aug 16.

15.

Genetic risk of prediabetes and diabetes development in chronic myeloid leukemia patients treated with nilotinib.

Martino B, Mammì C, Labate C, Rodi S, Ielo D, Priolo M, Postorino M, Tripepi G, Ronco F, Laganà C, Musolino C, Greco M, La Nasa G, Caocci G.

Exp Hematol. 2017 Nov;55:71-75. doi: 10.1016/j.exphem.2017.07.007. Epub 2017 Jul 28.

PMID:
28757432
16.

Disappearance of Bone Marrow Fibrosis in a Patient with Chronic Myeloid Leukemia Treated with Dasatinib.

Vigna E, Martino B, Bacci F, Recchia AG, Mendicino F, Morelli R, Mauro FR, Musolino C, Greco R, Lucia E, Sabattini E, Morabito F, Gentile M.

Chemotherapy. 2017;62(6):350-352. doi: 10.1159/000477796. Epub 2017 Jul 26.

17.

Standardisation of minimal residual disease in multiple myeloma.

Innao V, Allegra A, Russo S, Gerace D, Vaddinelli D, Alonci A, Allegra AG, Musolino C.

Eur J Cancer Care (Engl). 2017 Nov;26(6). doi: 10.1111/ecc.12732. Epub 2017 Jul 3. Review.

PMID:
28671297
18.

Raman spectroscopy differentiates between sensitive and resistant multiple myeloma cell lines.

Franco D, Trusso S, Fazio E, Allegra A, Musolino C, Speciale A, Cimino F, Saija A, Neri F, Nicolò MS, Guglielmino SPP.

Spectrochim Acta A Mol Biomol Spectrosc. 2017 Dec 5;187:15-22. doi: 10.1016/j.saa.2017.06.020. Epub 2017 Jun 15.

PMID:
28645097
19.

MicroRNA Profiling in Asthma: Potential Biomarkers and Therapeutic Targets.

Heffler E, Allegra A, Pioggia G, Picardi G, Musolino C, Gangemi S.

Am J Respir Cell Mol Biol. 2017 Dec;57(6):642-650. doi: 10.1165/rcmb.2016-0231TR.

PMID:
28489455
20.

Vertical Gastric Bypass with Fundectomy: Feasibility and 2-Year Follow-Up in a Series of Morbidly Obese Patients.

Zappa MA, Aiolfi A, Musolino C, Giusti MP, Lesti G, Porta A.

Obes Surg. 2017 Aug;27(8):2145-2150. doi: 10.1007/s11695-017-2620-y.

PMID:
28271378
21.

How gene polymorphisms can influence clinical response and toxicity following R-CHOP therapy in patients with diffuse large B cell lymphoma.

Falduto A, Cimino F, Speciale A, Musolino C, Gangemi S, Saija A, Allegra A.

Blood Rev. 2017 Jul;31(4):235-249. doi: 10.1016/j.blre.2017.02.005. Epub 2017 Feb 27. Review.

PMID:
28262268
22.

Telomerase and telomere biology in hematological diseases: A new therapeutic target.

Allegra A, Innao V, Penna G, Gerace D, Allegra AG, Musolino C.

Leuk Res. 2017 May;56:60-74. doi: 10.1016/j.leukres.2017.02.002. Epub 2017 Feb 7. Review.

PMID:
28196338
23.

Disappearance of Acquired Hemophilia A after Complete Remission in a Multiple Myeloma Patient.

Innao V, Allegra A, Morreale R, Russo S, Musolino C.

Turk J Haematol. 2017 Jun 5;34(2):184-185. doi: 10.4274/tjh.2016.0146. Epub 2017 Jan 12. No abstract available.

24.

Developing shared understandings of recovery and care: a qualitative study of women with eating disorders who resist therapeutic care.

Musolino C, Warin M, Wade T, Gilchrist P.

J Eat Disord. 2016 Dec 16;4:36. doi: 10.1186/s40337-016-0114-2. eCollection 2016.

25.

Anticancer Activity of Curcumin and Its Analogues: Preclinical and Clinical Studies.

Allegra A, Innao V, Russo S, Gerace D, Alonci A, Musolino C.

Cancer Invest. 2017 Jan 2;35(1):1-22. doi: 10.1080/07357907.2016.1247166. Epub 2016 Dec 20. Review.

PMID:
27996308
26.

Immature myeloid-derived suppressor cells: A bridge between inflammation and cancer (Review).

Musolino C, Allegra A, Pioggia G, Gangemi S.

Oncol Rep. 2017 Feb;37(2):671-683. doi: 10.3892/or.2016.5291. Epub 2016 Dec 5. Review.

PMID:
27922687
27.

Adoptive immunotherapy for hematological malignancies: Current status and new insights in chimeric antigen receptor T cells.

Allegra A, Innao V, Gerace D, Vaddinelli D, Musolino C.

Blood Cells Mol Dis. 2016 Nov;62:49-63. doi: 10.1016/j.bcmd.2016.11.001. Epub 2016 Nov 10. Review.

PMID:
27865176
28.

Splanchnic vein thrombosis in myeloproliferative neoplasms: risk factors for recurrences in a cohort of 181 patients.

De Stefano V, Vannucchi AM, Ruggeri M, Cervantes F, Alvarez-Larrán A, Iurlo A, Randi ML, Pieri L, Rossi E, Guglielmelli P, Betti S, Elli E, Finazzi MC, Finazzi G, Zetterberg E, Vianelli N, Gaidano G, Nichele I, Cattaneo D, Palova M, Ellis MH, Cacciola E, Tieghi A, Hernandez-Boluda JC, Pungolino E, Specchia G, Rapezzi D, Forcina A, Musolino C, Carobbio A, Griesshammer M, Barbui T.

Blood Cancer J. 2016 Nov 4;6(11):e493. doi: 10.1038/bcj.2016.103.

29.

A population-based study of chronic myeloid leukemia patients treated with imatinib in first line.

Castagnetti F, Di Raimondo F, De Vivo A, Spitaleri A, Gugliotta G, Fabbiano F, Capodanno I, Mannina D, Salvucci M, Antolino A, Marasca R, Musso M, Crugnola M, Impera S, Trabacchi E, Musolino C, Cavazzini F, Mineo G, Tosi P, Tomaselli C, Rizzo M, Siragusa S, Fogli M, Ragionieri R, Zironi A, Soverini S, Martinelli G, Cavo M, Vigneri P, Stagno F, Rosti G, Baccarani M.

Am J Hematol. 2017 Jan;92(1):82-87. doi: 10.1002/ajh.24591. Epub 2016 Nov 18.

30.

The chronic lymphocytic leukemia international prognostic index predicts time to first treatment in early CLL: Independent validation in a prospective cohort of early stage patients.

Molica S, Shanafelt TD, Giannarelli D, Gentile M, Mirabelli R, Cutrona G, Levato L, Di Renzo N, Di Raimondo F, Musolino C, Angrilli F, Famà A, Recchia AG, Chaffee KG, Neri A, Kay NE, Ferrarini M, Morabito F.

Am J Hematol. 2016 Nov;91(11):1090-1095. doi: 10.1002/ajh.24493. Epub 2016 Aug 8.

31.

Prospective Comparison and Quality of Life for Single-Incision and Conventional Laparoscopic Sleeve Gastrectomy in a Series of Morbidly Obese Patients.

Porta A, Aiolfi A, Musolino C, Antonini I, Zappa MA.

Obes Surg. 2017 Mar;27(3):681-687. doi: 10.1007/s11695-016-2338-2.

PMID:
27686234
32.

lncRNA profiling in early-stage chronic lymphocytic leukemia identifies transcriptional fingerprints with relevance in clinical outcome.

Ronchetti D, Manzoni M, Agnelli L, Vinci C, Fabris S, Cutrona G, Matis S, Colombo M, Galletti S, Taiana E, Recchia AG, Bossio S, Gentile M, Musolino C, Di Raimondo F, Grilli A, Bicciato S, Cortelezzi A, Tassone P, Morabito F, Ferrarini M, Neri A.

Blood Cancer J. 2016 Sep 9;6(9):e468. doi: 10.1038/bcj.2016.77.

33.

The metabolomic signature of hematologic malignancies.

Allegra A, Innao V, Gerace D, Bianco O, Musolino C.

Leuk Res. 2016 Oct;49:22-35. doi: 10.1016/j.leukres.2016.08.002. Epub 2016 Aug 8. Review.

PMID:
27526405
34.

Corneal Structural Changes in Nonneoplastic and Neoplastic Monoclonal Gammopathies.

Aragona P, Allegra A, Postorino EI, Rania L, Innao V, Wylegala E, Nowinska A, Ieni A, Pisani A, Musolino C, Puzzolo D, Micali A.

Invest Ophthalmol Vis Sci. 2016 May 1;57(6):2657-65. doi: 10.1167/iovs.15-18594.

PMID:
27177322
35.

Subcapsular hepatic haematoma of the right lobe following endoscopic retrograde cholangiopancreatography: Case report and literature review.

Zappa MA, Aiolfi A, Antonini I, Musolino CD, Porta A.

World J Gastroenterol. 2016 May 7;22(17):4411-5. doi: 10.3748/wjg.v22.i17.4411. Review.

36.

High rate of recurrent venous thromboembolism in patients with myeloproliferative neoplasms and effect of prophylaxis with vitamin K antagonists.

De Stefano V, Ruggeri M, Cervantes F, Alvarez-Larrán A, Iurlo A, Randi ML, Elli E, Finazzi MC, Finazzi G, Zetterberg E, Vianelli N, Gaidano G, Rossi E, Betti S, Nichele I, Cattaneo D, Palova M, Ellis MH, Cacciola R, Tieghi A, Hernandez-Boluda JC, Pungolino E, Specchia G, Rapezzi D, Forcina A, Musolino C, Carobbio A, Griesshammer M, Sant'Antonio E, Vannucchi AM, Barbui T.

Leukemia. 2016 Oct;30(10):2032-2038. doi: 10.1038/leu.2016.85. Epub 2016 Apr 26.

PMID:
27113812
37.

Extramedullary Plasmacytoma of the Maxilla Simulating a Maxillary Radicular Cyst: Quick Diagnosis and Management.

Allegra A, Nastro Siniscalchi E, Cicciù M, Bacci F, Catalfamo L, Innao V, De Ponte FS, Musolino C.

J Craniofac Surg. 2016 May;27(3):e296-7. doi: 10.1097/SCS.0000000000002539.

PMID:
27054435
38.

Rotation of nilotinib and imatinib for first-line treatment of chronic phase chronic myeloid leukemia.

Gugliotta G, Castagnetti F, Breccia M, Gozzini A, Usala E, Carella AM, Rege-Cambrin G, Martino B, Abruzzese E, Albano F, Stagno F, Luciano L, D'Adda M, Bocchia M, Cavazzini F, Tiribelli M, Lunghi M, Pia Falcone A, Musolino C, Levato L, Venturi C, Soverini S, Cavo M, Alimena G, Pane F, Martinelli G, Saglio G, Rosti G, Baccarani M; GIMEMA CML Working Party.

Am J Hematol. 2016 Jun;91(6):617-22. doi: 10.1002/ajh.24362. Epub 2016 Apr 24.

39.

Splenic rupture following colonoscopy: Case report and literature review.

Zappa MA, Aiolfi A, Antonini I, Musolino CD, Porta A.

Int J Surg Case Rep. 2016;21:118-20. doi: 10.1016/j.ijscr.2016.02.038. Epub 2016 Mar 4.

40.

A phase 2 study of three low-dose intensity subcutaneous bortezomib regimens in elderly frail patients with untreated multiple myeloma.

Larocca A, Bringhen S, Petrucci MT, Oliva S, Falcone AP, Caravita T, Villani O, Benevolo G, Liberati AM, Morabito F, Montefusco V, Passera R, De Rosa L, Omedé P, Vincelli ID, Spada S, Carella AM, Ponticelli E, Derudas D, Genuardi M, Guglielmelli T, Nozzoli C, Aghemo E, De Paoli L, Conticello C, Musolino C, Offidani M, Boccadoro M, Sonneveld P, Palumbo A.

Leukemia. 2016 Jun;30(6):1320-6. doi: 10.1038/leu.2016.36. Epub 2016 Feb 22.

41.

A micro-Raman spectroscopic investigation of leukemic U-937 cells in aged cultures.

Fazio E, Trusso S, Franco D, Nicolò MS, Allegra A, Neri F, Musolino C, Guglielmino SP.

Spectrochim Acta A Mol Biomol Spectrosc. 2016 Apr 15;159:21-9. doi: 10.1016/j.saa.2016.01.032. Epub 2016 Jan 21.

PMID:
26827173
42.

Triplet vs doublet lenalidomide-containing regimens for the treatment of elderly patients with newly diagnosed multiple myeloma.

Magarotto V, Bringhen S, Offidani M, Benevolo G, Patriarca F, Mina R, Falcone AP, De Paoli L, Pietrantuono G, Gentili S, Musolino C, Giuliani N, Bernardini A, Conticello C, Pulini S, Ciccone G, Maisnar V, Ruggeri M, Zambello R, Guglielmelli T, Ledda A, Liberati AM, Montefusco V, Hajek R, Boccadoro M, Palumbo A.

Blood. 2016 Mar 3;127(9):1102-8. doi: 10.1182/blood-2015-08-662627. Epub 2016 Jan 4. Erratum in: Blood. 2018 Mar 29;131(13):1495.

43.

A progression-risk score to predict treatment-free survival for early stage chronic lymphocytic leukemia patients.

Gentile M, Shanafelt TD, Cutrona G, Molica S, Tripepi G, Alvarez I, Mauro FR, Di Renzo N, Di Raimondo F, Vincelli I, Todoerti K, Matis S, Musolino C, Fabris S, Vigna E, Levato L, Zupo S, Angrilli F, Consoli U, Festini G, Longo G, Cortelezzi A, Arcari A, Federico M, Mannina D, Recchia AG, Neri A, Kay NE, Ferrarini M, Morabito F.

Leukemia. 2016 Jun;30(6):1440-3. doi: 10.1038/leu.2015.333. Epub 2015 Dec 9. No abstract available.

PMID:
26648537
44.

Possible Role of Interleukin-31/33 Axis in Imatinib Mesylate-Associated Skin Toxicity.

Musolino C, Allegra A, Mannucci C, Russo S, Alonci A, Maisano V, Calapai G, Gangemi S.

Turk J Haematol. 2015 Jun;32(2):168-71. doi: 10.4274/tjh.2014.0021.

45.

Vaccination strategies in lymphoproliferative disorders: Failures and successes.

Allegra A, Russo S, Gerace D, Calabrò L, Maisano V, Innao V, Musolino C.

Leuk Res. 2015 Oct;39(10):1006-19. doi: 10.1016/j.leukres.2015.08.001. Epub 2015 Aug 5. Review.

PMID:
26298174
46.

Castleman-Kojima disease (TAFRO syndrome) in a Caucasian patient: A rare case report and review of the literature.

Allegra A, Rotondo F, Russo S, Calabrò L, Maisano V, Bacci F, Musolino C.

Blood Cells Mol Dis. 2015 Oct;55(3):206-7. doi: 10.1016/j.bcmd.2015.06.013. Epub 2015 Jun 25. No abstract available.

PMID:
26227845
47.

Efficacy of biosimilar granulocyte colony-stimulating factor versus originator granulocyte colony-stimulating factor in peripheral blood stem cell mobilization in de novo multiple myeloma patients.

Martino M, Recchia AG, Moscato T, Fedele R, Neri S, Gentile M, Alati C, Vincelli ID, Piro E, Penna G, Musolino C, Ronco F, Molica S, Morabito F.

Cytotherapy. 2015 Oct;17(10):1485-93. doi: 10.1016/j.jcyt.2015.05.010. Epub 2015 Jul 15.

PMID:
26188967
48.

Phage-AgNPs complex as SERS probe for U937 cell identification.

Lentini G, Fazio E, Calabrese F, De Plano LM, Puliafico M, Franco D, Nicolò MS, Carnazza S, Trusso S, Allegra A, Neri F, Musolino C, Guglielmino SP.

Biosens Bioelectron. 2015 Dec 15;74:398-405. doi: 10.1016/j.bios.2015.05.073. Epub 2015 Jun 28.

PMID:
26164011
49.

'Healthy anorexia': The complexity of care in disordered eating.

Musolino C, Warin M, Wade T, Gilchrist P.

Soc Sci Med. 2015 Aug;139:18-25. doi: 10.1016/j.socscimed.2015.06.030. Epub 2015 Jun 27.

PMID:
26150064
50.

Vaccination of multiple myeloma: Current strategies and future prospects.

Allegra A, Penna G, Innao V, Greve B, Maisano V, Russo S, Musolino C.

Crit Rev Oncol Hematol. 2015 Nov;96(2):339-54. doi: 10.1016/j.critrevonc.2015.06.003. Epub 2015 Jun 18. Review.

PMID:
26123319

Supplemental Content

Loading ...
Support Center